Glenmark net profit up 132% at Rs 132cr

BS 200 Scorecard

Riding on a blistering 32 per cent growth in domestic business and excise benefit from the Baddi plant, Mumbai-based Glenmark Pharmaceuticals Ltd has posted a 132.24 per cent rise in its net profit on a standalone basis.

The profit stood at Rs 32.05 crore for the quarter ended September 30 this year, up from Rs 13.8 crore last year.

The total revenue stood at Rs 204 crore this quarter end, up 47.83 per cent from Rs 138 crore last year.

On a consolidated basis "" an aggregate that the company didn't come out with till last year "" the profits stood at Rs 40.2 crore and total revenues at Rs 255.7 crore this quarter.

The revenues this year have come largely from the company's operations in the US market.